-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
Search results for: “patient perspective”
-
See You in Seoul: Inside WCLC 2026
Hear from the Conference Chairs as they discuss networking opportunities, new session formats, and more.
-
Amazing Case Race Returns to WCLC 2026
Alan Nguyen, IASLC Education Coordinator, shares how the interactive competition has grown in both participation and diversity of perspectives from around the globe.
-
From Access to Eligibility: What Poland’s Real-World Stage III NSCLC Data Reveal About Treatment Pathways and Health Policy
Dr. Łukasz Kuncman expands on findings from a multicenter Polish study analyzing referral patterns and clinical practice in patients with unresectable stage III NSCLC, emphasizing that access to the modern standard of care depends on a chain of eligibility.
-
Knowing Before We Can Act: The Value of MRD Testing From a Patient’s Perspective
While MRD testing does not eliminate the uncertainty of recurrence, Jan Pezarro explains how advanced molecular testing provides invaluable clarity for patients.
-
IASLC Spotlight: Basic and Translational Science Committee
From the VIKTOR platform to the upcoming IASLC Hot Topics meeting, Dr. Tom John discusses the committee’s long-term goals, ongoing projects, and future directions.
-
Under Therapeutic Pressure: ELCC Session Highlights How Tumor Switching is Reshaping the Treatment Landscape
Experts emphasize the need for multidisciplinary approaches, personalized therapies, and strategies to address intratumor heterogeneity.
-
Leading by Example: A Message of Resilience, Gratitude, and Hope
During a special session at TTLC 2026, Dr. Ross Camidge shared his personal journey with lung cancer, discussing its impact on both his professional and personal life.
-
Advocate Calls for Stronger Patient Partnerships in Clinical Research
Jane Perlmutter, a survivor of multiple cancers, encouraged investigators to involve patient advocates at every stage of research during the TTLC 2026 Patient Advocate Session.
-
Expert Commentary on the Clinical and Surgical Implications of VPI in NSCLC
Dr. Ramón Rami-Porta offers a surgical perspective on the secondary analysis of the CALGB 140503 trial and discusses what, if any, influence the data will have on staging guidelines.
-
A Comprehensive Framework: Integrating Smoking Cessation into LCS
Experts outline how Poland aims to reduce lung cancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.
View ILCN Archives
Provider Resources
Popular Articles